Botulinum neurotoxins: More and more diverse and fascinating toxic proteins

Journal of Infectious Diseases

Volumn 209, Issue 2, 2014, Pages 168-169

  Popoff, Michel R ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

Botulinum neurotoxin; Botulinum toxin type; Botulism; Clostridium botulinum

Indexed keywords

BOTULINUM TOXIN; BOTULINUM TOXIN A; BOTULINUM TOXIN B; NEUROTRANSMITTER; SNARE PROTEIN; SYNAPTIC VESICLE PROTEIN; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; SYNAPTOTAGMIN I; SYNAPTOTAGMIN II; SYNTAXIN; UNCLASSIFIED DRUG;

BINDING AFFINITY; BOTULISM; CLOSTRIDIUM; CLOSTRIDIUM BOTULINUM; CLOSTRIDIUM BOTULINUM TYPE A; CLOSTRIDIUM BOTULINUM TYPE B; CLOSTRIDIUM BOTULINUM TYPE C; CLOSTRIDIUM BOTULINUM TYPE D; CLOSTRIDIUM BOTULINUM TYPE E; CLOSTRIDIUM SPOROGENES; CLOSTRIDIUM SUBTERMINALE; DNA SEQUENCE; FOOD INTAKE; FOOD POISONING; HUMAN; NERVE EXCITABILITY; NEUROTRANSMITTER RELEASE; NONHUMAN; NOTE; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; TAXONOMY; UNITED STATES;

EID: 84891537085     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit505     Document Type: Note

References (13)

1. Erbguth FJ, Naumann M. Historical aspects of botulinum toxin. Justinus Kerner (1786- 1862) and the sausage poison. Neurol 1999; 53:1850-3
2. Pickett J, Berg B, Chaplin E, Brunstetter- Shafer M. Syndrome of botulism in infancy: Clinical and electrophysiologic study. N Engl J Med 1976; 295:770-2
3. Mccroskey LM, Hatheway CL. Laboratory findings in four cases of adult botulism suggest colonization of the intestinal tract. J Clin Microbiol 1988; 26:1052-4
4. Arnon SS. Infant botulism: Anticipating the second decade. J Infect Dis 1986; 154:201-6
5. Arnon SS. Creation and development of the public service orphan drug Human Botulism Immune Globulin. Pediatrics 2007; 119:785-9
6. Smith LDS. Clostridium tetani Smith LDS, ed. The Pathogenic Anaerobic Bacteria Charles C. Springfield, IL: Thomas Publisher, 1975:177-201
7. Popoff MR, Bouvet P. Genetic characteristics of toxigenic Clostridia and toxin gene evolution. Toxicon 2013; doi:pii: S0041-0101(13) 00246-8).
8. Rummel A. Double receptor anchorage of botulinum neurotoxins accounts for their exquisite neurospecificity. Curr Top Microbiol Immunol 2013; 364:61-90. doi:10.1007/978- 3-642-33570-94
9. Poulain B, Popoff MR, Molgo J. How do the botulinum neurotoxins block neurotransmitter release: From botulism to the molecular mechanism of action. Botulinum J 2008; 1:14-87
10. Tighe AP, Schiavo G. Botulinum neurotoxins: Mechanism of action. Toxicon 2012; 67:14-87
11. Dover N, Barash JR, Hill KK, et al. Clostridium botulinum strain Af84 contains three neurotoxin gene clusters: Bont/A2, bont/F4 and bont/F5. PLoS One 2013; 8:e61205
12. Barash JR, Arnon SS. A novel strain of Clostridium botulinum that produces type B and type H botulinum toxins. J Infect Dis 2014; 209:183-91
13. Dover N, Barash JR, Hill KK, et al. Molecular characterization of a novel botulinum neurotoxin type H gene. J Infect Dis 2014; 209: 192-202